Influence of unsaturated carbonic acids on hemocompatibility and cytotoxicity of poly-vinylacetate based co-polymers

Journal of Materials Science: Materials in Medicine

Volumn 21, Issue 5, 2010, Pages 1693-1702

  Tavakalyan, N B ^a   Karapetyan, A G ^b   Pogosyan, A S ^b   Abrahamyan, A K ^b   Corti, A ^c   Pompella, A ^c   Mihranyan, A ^d  

^a Plastpolymer Yerevan Scientific Research Institute   (Armenia)

^b Center of Radiation Medicine and Burns   (Armenia)

^c UNIVERSITY OF PISA   (Italy)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION PROPERTIES; BONE MARROW; CARBONIC ACIDS; CARBOXYLIC GROUP; CHROMOSOME ABERRATION; CROTONIC ACIDS; CYTOTOXIC EFFECTS; DRUG-ELUTING STENTS; ERYTHROCYTE AGGREGATION; HEMOCOMPATIBILITY; HIGH WATER CONTENT; HOMOPOLYMERS; HUMAN ENDOTHELIAL CELLS; IN-VITRO; ITACONIC ACID; LIPID PEROXIDATION LEVELS; MALEIC ACIDS; METAL SAMPLES; METAL SUBSTRATE; METAL-SUPPORTS; PROLIFERATION ACTIVITY; PROMISING MATERIALS; SYNTHETIC POLYMERS;

ADHESION; BLOOD; BONE; CARBON DIOXIDE; CYTOTOXICITY; ENDOTHELIAL CELLS; METALS; ORGANIC ACIDS; PLASTIC COATINGS; POLYMERS; RATS; STAINLESS STEEL; SUBSTRATES; TITANIUM; WATER CONTENT;

UNSATURATED POLYMERS;

BIOMATERIAL; COPOLYMER; CROTONIC ACID DERIVATIVE; HEMOGLOBIN; ITACONIC ACID; MALEIC ACID; POLYVINYL ACETATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; ERYTHROCYTE AGGREGATION; HEMOLYSIS; IN VITRO STUDY; LIPID PEROXIDATION; NONHUMAN; PLOIDY; PRIORITY JOURNAL; RAT; THROMBOCYTE COUNT; WETTABILITY;

ANIMALS; CARBONIC ACID; CELL ADHESION; DRUG-ELUTING STENTS; HUMANS; MALE; METALS; MIDDLE AGED; POLYMERS; RATS; TITANIUM; WATER;

RATTUS;

EID: 77954536115     PISSN: 09574530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10856-010-4020-x     Document Type: Article

References (34)

1. Lau KW, Mak KH, Hung JS, Sigwart U. Clinical impact of stent construction and design in percutaneous coronary intervention. Am Heart J. 2004;147(5):764-773 (Pubitemid 38880980)
2. Lev EI, Assali AR, Teplisky I, Rechavia E, Hasdai D, Sela O, et al. Comparison of outcomes up to six months of heparin-coated with noncoated stents after percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2004;93(6):741-743
3. Lewis AL, Stratford PW. Phosphorylcholine-coated stents. J Long Term Eff Med Implants. 2002;12(4):231-250
4. Ramsdale DR. Coronary artery stenting. Hosp Med. 1999;60(9): 624-629
5. Schuler G. Polymer-sirolimus-eluting stents in de novo lesions. Herz. 2004;29(2):152-161
6. Sigwart U. Coronary stents. Z Kardiol. 1995;84:65-77.
7. Mani G, Feldman MD, Patel D, Agrawal CM. Coronary stents: a materials perspective. Biomaterials. 2007;28(9):1689-1710
8. Taylor A. Metals. In: Sigwart U, editor. Endoluminal stenting. London: W.B. Saunders Company Ltd; 1996. p. 28-33.
9. Haudrechy P, Foussereau J, Mantout B, Baroux B. Nickel release from 304 and 316 stainless-steels in synthetic sweat-comparison with nickel and nickel-plated metals-consequences on allergic contact dermatitis. Corros Sci. 1993;35(1-4):329-336
10. Koster R, Vieluf D, Kiehn M, Sommerauer M, Kahler J, Baldus S, et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 2000;356(9245):1895-1897
11. Davis JR. Metallic materials. Materials Park, Ohio: ASM International; 2003.
12. Park JB, Kim YK. Metallic biomaterials. In: Park JB, Bronzio JD, editors. Biomat principles and applications. Boca Raton: CRC Press; 2003. p. 1-20.
13. Mueller PP, May T, Perz A, Hauser H, Peuster M. Control of smooth muscle cell proliferation by ferrous iron. Biomaterials. 2006;27(10):2193-2200
14. Peuster M, Hesse C, Schloo T, Fink C, Beerbaum P, von Schnakenburg C. Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta. Biomaterials. 2006;27(28):4955-4962
15. Peuster M, Wohlsein P, Brugmann M, Ehlerding M, Seidler K, Fink C, et al. A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal-results 6-18 months after implantation into New Zealand white rabbits. Heart. 2001;86(5):563-569
16. Gottsauner-Wolf M, Moliterno DJ, Lincoff AM, Topol EJ. Restenosis-an open file. Clin Cardiol. 1996;19(5):347-356
17. Wijns W. Late stent thrombosis after drug-eluting stent: seeing is understanding. Circulation. 2009;120(5):364-365
18. Bailey SR. DES design: theoretical advantages and disadvantages of stent strut materials, design, thickness, and surface characteristics. J Interv Cardiol. 2009;22(s1):s3-17.
19. Depalma VA, Baier RE, Gott VL, Ford JW, Furuse A. Investigation of 3-surface properties of several metals and their relation to blood compatibility. J Biomed Mater Res. 1972;6(4):37-75.
20. Dev V, Eigler N, Sheth S, Lambert T, Forrester J, Litvack F. Kinetics of drug delivery to the arterial wall via polyurethanecoated removable nitinol stent: comparative study of two drugs. Cathet Cardiovasc Diagn. 1995;34(3):272-278
21. Lambert TL, Dev V, Rechavia E, Forrester JS, Litvack F, Eigler NL. Localized arterial wall drug delivery from a polymer-coated removable metallic stent. Kinetics, distribution, and bioactivity of forskolin. Circulation. 1994;90(2):1003-1011
22. Cooper SL, Visser SA, Hergenrother RW, Lamba NMK. Polymers. Biomaterials science an introduction to materials in medicine. San Diego: Elsevier Academic Press; 2004. p. 67-79.
23. Murphy JG, Schwartz RS, Edwards WD, Camrud AR, Vliestra RE, Holmer DR. Percutaneous polymeric stents in porcine coronary artery initial experience with polyethylene terephtalate stents. Circulation. 1992;86(5):1596-1604
24. Peng T, Gibula P, Yao KD, Goosen MF. Role of polymers in improving the results of stenting in coronary arteries. Biomaterials. 1996;17(7):685-694
25. Tan LP, Venkatraman SS, Sung PF, Wang XT. Effect of plasticization on heparin release from biodegradable matrices. Int J Pharm. 2004;283(1-2):89-96.
26. Banai S, Gertz SD, Gavish L, Chorny M, Perez LS, Lazarovichi G, et al. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries. Cardiovasc Res. 2004;64(1): 165-171
27. van der Giessen WJ, Lincoff AM, Schwartz RS, van Beusekom HM, Serruys PW, Holmes DR Jr, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation. 1996;94(7): 1690-1697
28. Richard R, Schwarz M, Chan K, Teigen N, Boden M. Controlled delivery of paclitaxel from stent coatings using novel styrene maleic anhydride copolymer formulations. J Biomed Mater Res Part A. 2008;90A(2):522-532
29. Edelman ER, Adams DH, Karnovsky MJ. Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc Natl Acad Sci USA. 1990; 87(10):3773-3777
30. Final Report on the Safety Assessment of Vinyl Acetate/Crotonic Acid Copolymer. Int J Tox 1983;2(5):125-140
31. Kabanov VY. Preparation of polymeric biomaterials with the aid of radiation-chemical methods. Russ Chem Rev. 1998;67:783-816.
32. Jozefowicz M, Jozefonvicz J. Antithrombogenic polymers. Pure Appl Chem. 1985;56(10):1335-1344
33. Lundell EO, Byck JS, Kwiatkowski GT, Osterholts FD, Creasy WS, Stewart DD. Biological and physical characterization of some polyelectrolytes. Polym Prepr Am Chem Soc, Div Polym Chem. 1975;16(2):541-544
34. Shtilman MI. Polymeric biomaterials. Part I. Polymer implants. Utrecht-Boston: VSP Books; 2003.